Avoid Mix-Ups With the New Antipsychotics Caplyta and Secuado

Caplyta (kah-PLY-tah, lumateperone) and Secuado (seh-KWAH-doh, asenapine) will be two new atypical antipsychotics for schizophrenia.

Caplyta is a 42 mg oral capsule that's taken once daily.

Expect it to be saved for patients who don't respond to or can't tolerate lower-cost atypicals, such as olanzapine or risperidone.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote